Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
MAAS · Nasdaq · United States · Investment Advice
In shortMaase Inc. is loss-making.
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -88.5% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -25.1% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -20.4% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 8.4% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 426.6% | 0/100 |
| Operating margin volatility | 21.5% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 60.6% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CNY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 193 | 189 | 114 | 1,185 | 781 |
| Cost of revenue | 44 | 34 | 20 | – | – |
| Gross profit | 149 | 155 | 94 | – | – |
| Operating income | (73) | (74) | (59) | (463) | (691) |
| Pre-tax income | (56) | (62) | (44) | (516) | (337) |
| Income tax | (9.6) | (0.9) | 8.6 | 14 | (20) |
| Net income | (46) | (61) | (44) | (290) | (196) |
| Diluted EPS | −¥0.51 | −¥0.67 | −¥43.35 | −¥113.55 | −¥25.86 |
| Diluted shares (millions) | 90 | 90 | 1 | 2.6 | 7.6 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice.
Latest annual report: Jun 30, 2025 · Data updated Oct 29, 2025